Senior Independent Non-Executive Director, and Chairman of the Board Audit and Risk Committee
Nick joined the Board of the Bank in 2013. He was the Managing Director of Frontier Markets Fund Managers, a division of Standard Bank Plc from 2005 until 2014. His involvement with the Emerging Africa Infrastructure Fund (EAIF), a fund managed by the Frontier Markets dates from its inception. Prior to this Nick worked in Barclays Bank for 33 years in various capacities including in Africa for 7 years initially running Barclays Corporate Business in East Africa and subsequently as Head of Credit Risk for Africa and the Middle East.
He presently is the Non-Executive Chairman of the Credit Investment Committee of CDC Group Plc. His earlier speaking engagements include invitations to Harvard Business School, Oxford Said Business School and World Bank Group.
Non-Executive Director and member of the Board Audit & Risk Committee
Roger Ellender has over forty years’ experience in investment and commercial banking, in emerging markets (Africa, Middle East and Asia) with such global financial institutions as Bank of America, BNPP, Standard Chartered Bank, Credit Suisse and UBS. He has spent the past twenty years in Nigeria working in a number of financial institutions, mainly in Business Origination, Risk Management, Operations, Compliance and Controls. From 2009 – 2015, Roger was the Chief Risk Officer at Africa Finance Corporation (AFC), Lagos, before leaving to establish his own financial consultancy and advisory business.
Roger is currently the Managing Director of NPL Nigeria, Lagos, which is a subsidiary of NPL Advisors Limited, London, and which is focused on providing financing solutions for clients in Sub Saharan Africa. He is a Non-Executive Director of First City Monument Bank Limited, Nigeria and serves on several board committees including the Credit, Audit & Risk Management and IT committees. Roger has a BA (Hons) from the University of Liverpool and an MA from the University of Essex. He is an Alumnus of INSEAD, Fontainebleau, France and IMD, Lausanne, Switzerland.